Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 15, 2020 07:00 ET | Source: Surrozen, Inc.

Surrozen Awarded NIH Grant to Support Development of SZN-043, a Liver-Specific Regenerative Antibody, for the Treatment of Severe Alcoholic Hepatitis

SOUTH SAN FRANCISCO, Calif., Oct. 15, 2020 (GLOBE NEWSWIRE) -- Surrozen Inc., a biotechnology company pioneering a new class of targeted regenerative antibodies, has been awarded an NIH grant to...
September 25, 2020 07:00 ET | Source: Surrozen, Inc.

Surrozen Expands Board of Directors with Appointment of David J. Woodhouse, Ph.D.

SOUTH SAN FRANCISCO, Calif., Sept. 25, 2020 (GLOBE NEWSWIRE) -- Surrozen Inc., a biotechnology company pioneering a new class of targeted regenerative antibodies, today announced the addition of...
September 16, 2020 07:00 ET | Source: Surrozen, Inc.

Surrozen to Present at Morgan Stanley 18th Annual Global Healthcare Conference

-- Craig Parker, CEO of Surrozen, to present Surrozen’s advancements in regenerative medicine -- SOUTH SAN FRANCISCO, Calif., Sept. 16, 2020 (GLOBE NEWSWIRE) -- Surrozen Inc., a biotechnology...
August 19, 2020 10:00 ET | Source: Surrozen, Inc.

Surrozen Announces Publication of Second Antibody Platform Technology in Scientific Reports

-- Novel approach to creating R-spondin-mimetics establishes proof-of-concept for targeted regenerative antibodies -- SOUTH SAN FRANCISCO, Calif., Aug. 19, 2020 (GLOBE NEWSWIRE) -- Surrozen Inc.,...
June 19, 2020 10:00 ET | Source: Surrozen, Inc.

UPDATE -- Surrozen Raises $50 Million in Series C Financing to Advance Candidates to Human Clinical Trials

SOUTH SAN FRANCISCO, Calif., June 19, 2020 (GLOBE NEWSWIRE) -- Surrozen Inc., a biotechnology company pioneering a new class of targeted regenerative antibodies, today announced the successful...
June 19, 2020 07:00 ET | Source: Surrozen, Inc.

Surrozen Raises $50 Million in Series C Financing to Advance Candidates to Human Clinical Trials

SOUTH SAN FRANCISCO, Calif., June 19, 2020 (GLOBE NEWSWIRE) -- Surrozen Inc., a biotechnology company pioneering a new class of targeted regenerative antibodies, today announced the successful...
May 04, 2020 10:00 ET | Source: Surrozen, Inc.

Surrozen Announces Publication of Two Abstracts Providing Evidence for Liver-Targeted Tissue Regeneration

-- Abstracts originally accepted for 2020 Digestive Disease Week Conference – to be published online -- SOUTH SAN FRANCISCO, Calif., May 04, 2020 (GLOBE NEWSWIRE) -- Surrozen Inc., a...
April 06, 2020 10:00 ET | Source: Surrozen, Inc.

Surrozen Scientific Founder Roel Nusse, PhD Receives Prestigious Canada Gairdner International Award for Biomedical Research

SOUTH SAN FRANCISCO, Calif., April 06, 2020 (GLOBE NEWSWIRE) -- Surrozen Inc., a biotechnology company pioneering a new class of targeted regenerative antibodies, today announced that one of its...
March 30, 2020 13:42 ET | Source: Surrozen, Inc.

Surrozen Announces Publication of Antibody Platform Technology in Cell Chemical Biology

-- Novel approach to creating Wnt-mimetics establishes proof-of-concept for targeted regenerative antibodies -- SOUTH SAN FRANCISCO, Calif., March 30, 2020 (GLOBE NEWSWIRE) -- Surrozen Inc., a...
March 02, 2020 10:00 ET | Source: Surrozen, Inc.

Surrozen to Present at Cowen and Company 40th Annual Health Care Conference

SOUTH SAN FRANCISCO, Calif., March 02, 2020 (GLOBE NEWSWIRE) -- Surrozen, Inc., a biotechnology company pioneering a new class of targeted regenerative antibodies to repair a broad range of tissues,...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right